These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37354093)

  • 1. Cannabis use among adults undergoing cancer treatment.
    Azizoddin DR; Cohn AM; Ulahannan SV; Henson CE; Alexander AC; Moore KN; Holman LL; Boozary LK; Sifat MS; Kendzor DE
    Cancer; 2023 Nov; 129(21):3498-3508. PubMed ID: 37354093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of adults with a medical cannabis license, reasons for use, and perceptions of benefit following medical cannabis legalization in Oklahoma.
    Kendzor DE; Ehlke SJ; Kharazi Boozary L; Smith MA; Cohn AM
    Prev Med Rep; 2022 Jun; 27():101777. PubMed ID: 35392181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use among cancer patients and survivors in the United States: a systematic review.
    Amin S; Chae SW; Kawamoto CT; Phillips KT; Pokhrel P
    JNCI Cancer Spectr; 2024 Jan; 8(1):. PubMed ID: 38291891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Oncologists Recommend Cannabis?
    Abrams DI
    Curr Treat Options Oncol; 2019 Jun; 20(7):59. PubMed ID: 31161270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers.
    Ellison GL; Helzlsouer KJ; Rosenfield SM; Kim Y; Ashare RL; Blaes AH; Cullen J; Doran N; Ebbert JO; Egan KM; Heffner JL; Lee RT; McClure EA; McDaniels-Davidson C; Meghani SH; Newcomb PA; Nugent S; Hernandez-Ortega N; Salz T; Vidot DC; Worster B; Zylla DM
    J Natl Cancer Inst Monogr; 2024 Aug; 2024(66):202-217. PubMed ID: 39108244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment.
    Weiss MC; Hibbs JE; Buckley ME; Danese SR; Leitenberger A; Bollmann-Jenkins M; Meske SW; Aliano-Ruiz KE; McHugh TW; Larson SL; Le EH; Green NL; Gilman PB; Kaklamani VG; Chlebowski RT; Martinez DM
    Cancer; 2022 Jan; 128(1):160-168. PubMed ID: 34636036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center.
    Raghunathan NJ; Brens J; Vemuri S; Li QS; Mao JJ; Korenstein D
    Support Care Cancer; 2022 Sep; 30(9):7491-7497. PubMed ID: 35665859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada.
    Hawley P; Gobbo M
    Curr Oncol; 2019 Aug; 26(4):e425-e432. PubMed ID: 31548810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain.
    Cranford JA; Arnedt JT; Conroy DA; Bohnert KM; Bourque C; Blow FC; Ilgen M
    Drug Alcohol Depend; 2017 Nov; 180():227-233. PubMed ID: 28926791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
    Abu-Amna M; Salti T; Khoury M; Cohen I; Bar-Sela G
    Curr Treat Options Oncol; 2021 Jan; 22(2):16. PubMed ID: 33439370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perception of Benefits and Harms of Medical Cannabis among Seriously Ill Patients in an Outpatient Palliative Care Practice.
    Zarrabi AJ; Welsh JW; Sniecinski R; Curseen K; Gillespie T; Baer W; McKenzie-Brown AM; Singh V
    J Palliat Med; 2020 Apr; 23(4):558-562. PubMed ID: 31539298
    [No Abstract]   [Full Text] [Related]  

  • 13. Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review.
    Vinette B; Côté J; El-Akhras A; Mrad H; Chicoine G; Bilodeau K
    BMC Cancer; 2022 Mar; 22(1):319. PubMed ID: 35331185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
    Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
    BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Cannabis Use and Perceived Benefit in a Tertiary Headache Center Patient Sample.
    Starkey B; Pearlson GD; Bond D; Glaser C; Bhargava A; Grosberg BM; Verhaak A
    Neurol Clin Pract; 2024 Apr; 14(2):e200285. PubMed ID: 38455123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent substance use among cancer patients with and without a history of cannabis use since cancer diagnosis at an NCI-Designated Cancer Center in Florida.
    Islam JY; Nguyen OT; Turner K; Martinez YC; Rodriguez OG; Rodriguez DI; Rajasekhara S; Chang YD; Gonzalez BD; Jim HSL; Egan KM
    J Natl Cancer Inst Monogr; 2024 Aug; 2024(66):224-233. PubMed ID: 39108241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Marijuana for Pain Management in Hospice Care as a Complementary Approach to Scheduled Opioids: A Single Arm Study.
    Zanker T; Sacco J; Prota J; Palma M; Viola Lee KA; Wang RR; Liang Y; Cunningham J; Mackary M; Ovchinnikova P
    Am J Hosp Palliat Care; 2024 Sep; 41(9):1002-1010. PubMed ID: 38100655
    [No Abstract]   [Full Text] [Related]  

  • 18. Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.
    Turgeman I; Bar-Sela G
    Expert Opin Investig Drugs; 2019 Mar; 28(3):285-296. PubMed ID: 30572744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, reasons for use, perceived benefits, and awareness of health risks of cannabis use among cancer survivors - implications for policy and interventions.
    Osaghae I; Chido-Amajuoyi OG; Talluri R; Shete S
    J Cancer Surviv; 2023 Dec; ():. PubMed ID: 38158514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry.
    Kasvis P; Canac-Marquis M; Aprikian S; Vigano M; Vigano A
    Support Care Cancer; 2022 Oct; 30(10):7863-7871. PubMed ID: 35723729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.